Efficacy and safety of crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC).
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Sai-Hong Ignatius Ou, Yung-Jue Bang, D. Ross Camidge, Gregory J. Riely, Ravi Salgia, Geoffrey Shapiro, Benjamin J. Solomon, Jeffrey A. Engelman, Eunice Lee Kwak, Jeffrey W. Clark, Lesley Tye, Keith D. Wilner, Patricia Stephenson, Marileila Varella-Garcia, Kristin Bergethon, Anthony John Iafrate, Alice Tsang Shaw
Institutions: UC Irvine Chao Family Comprehensive Cancer Center, Seoul National University Hospital, University of Colorado Cancer Center, Memorial Sloan Kettering Cancer Center, University of Chicago, Dana-Farber Cancer Institute, Peter MacCallum Cancer Centre, Peter MacCallum Cancer Foundation, Massachusetts General Hospital, Harvard University, Pfizer (United States), Rho (United States), University of Colorado Anschutz, University of Colorado Denver, Duke University, Duke Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2174680146